Results 181 to 190 of about 132,691 (312)

Serum Hepatitis B Virus DNA, RNA, and HBsAg: Which Correlated Better with Intrahepatic Covalently Closed Circular DNA before and after Nucleos(t)ide Analogue Treatment?

Journal of Clinical Microbiology, 2017
Yuhua Gao, Yutang Li, Q. Meng, Zhan-qing Zhang, P. Zhao, Q. Shang, Yuebao Li, Ming-ze Su, Tong Li, Xueen Liu, Zhuang Hui   +10 more
semanticscholar   +1 more source

Serological detection and epidemiological analysis of HBV among butchers in Khartoum State. [PDF]

Sci Rep
Sharif AAOM, Mohamedsharif AA, Mohammed IBS, Abdalla WM.   +3 more
europepmc   +1 more source

Effects of amino acid substitutions in hepatitis B virus surface protein on virion secretion, antigenicity, HBsAg and viral DNA.

Journal of Hepatology, 2017
Kuanhui Xiang, E. Michailidis, Hai Ding, Ya-qin Peng, Ming-ze Su, Yao Li, Xueen Liu, V. L. Dao Thi, Xianfang Wu, W. Schneider, Charles M. Rice, H. Zhuang, Tong Li   +12 more
semanticscholar   +1 more source

Efficacy of NAs in combination with Peg-IFN for functional cure in patients with CHB: a meta-analysis of RCTs. [PDF]

Ann Med
Zhang Y, Zhang Z, Li X, Cao W, Wang S, Deng W, Wei X, Yao L, Xie Y, Li M.   +9 more
europepmc   +1 more source

Machine Learning-Enhanced MALDI-TOF Mass Spectrometry for Screening HBsAg-Positive Patients. [PDF]

Microorganisms
Zhang T, Huang S, Li J, Wu Y, Zhao X, Gao H, Yang J, Yang L, Cao L, Xie X, Zhao H, Cheng J, Tan H, Li Y, Wu Q.   +14 more
europepmc   +1 more source

HBV and HCV Burden in a Greek Hospital Population (2018-2024): Trends and Correlates of HBsAg and Anti-HCV Positivity. [PDF]

Pathogens
Georgiadis N, Seitopoulou C, Kimouli M, Sergentanis TN, Beloukas A, Tzanakaki G.   +5 more
europepmc   +1 more source

Therapeutic hepatitis B vaccine employing DNA prime - MVA boost scheme requires additional priming with recombinant HBsAg to elicit an adequate antibody response. [PDF]

Front Immunol
Kerth HA, Kächele M, Müller N, Singh S, Tulessin M, Sacherl J, Ates Öz E, Su J, Bester R, Miko S, Steiger K, Mogler C, Busch DH, Wettengel JM, Protzer U, Kosinska AD.   +15 more
europepmc   +1 more source

Predictive role of serum HBsAg and HBcrAg kinetics in patients with HBeAg-negative chronic hepatitis B receiving pegylated interferon-based therapy.

Clinical Microbiology and Infection, 2017
N. Chuaypen, Nawarat Posuwan, S. Chittmittraprap, N. Hirankarn, S. Treeprasertsuk, Yasuhito Tanaka, N. Shinkai, Y. Poovorawan, P. Tangkijvanich   +8 more
semanticscholar   +1 more source

Reconsidering antiviral prophylaxis in HBsAg-negative, anti-HBc-positive patients treated with rituximab. [PDF]

Hepatol Commun
Papatheodoridis G, Hwang J.
europepmc   +1 more source

Long-term HBsAg clearance, relapse, and safety following tenofovir or entecavir discontinuation in non-cirrhotic, HBeAg-negative chronic hepatitis. [PDF]

Sci Rep
Sattayalertyanyong O, Bandidniyamanon W, Limsrivilai J, Chotiyaputta W, Nimanong S, Tanwandee T.   +5 more
europepmc   +1 more source